Search results for: Institute for Clinical and Economic Review (ICER)
Filter search results
Register Now: OHE Lunchtime Seminar on Innovation
26 June 2012
…that covers all 247 active R&D UK therapeutics firms, both public and private, founded between 1980 and 2009. Dr Hopkins’s research follows these SMEs for their entire funding cycles, revealing…
New Publication: Four Case Studies to Explore the Added Value of Oxford AHSN
13 September 2016
…value of the various projects and programmes that the network has developed and implemented since it was established in 2013. In order to do this, OHE and RAND Europe conducted…
EQ-5D and the EuroQol Group: Past, Present and Future
17 March 2017
…the future might hold for the further development and use of EQ-5D instruments in HTA and other applications. A new article has been published in Applied Health Economics and Health…
Opportunity Cost in Health Care: a Favourite Research Topic for OHE
23 November 2021
…For example, our research in Wales and in Scotland sought to understand how disinvestment and displacement might operate in the NHS, and what that might mean for opportunity costs. Cost-effectiveness…
Surveillance and Early Diagnosis and General Practice
1 July 1966
…stage which early diagnosis and screening, for example in diabetes and glaucoma, had reached in this country. To supplement this, Professor Jungner and Dr Collen were asked to describe briefly…
Viral Hepatitis in Britain
1 January 1977
…the liver which may lead to clinical ‘yellow jaundice’, they are caused by different viruses and have contrasting aetiologies and epidemiologies. The first, which is now generally referred to as…
Costs and Benefits of Regulating New Product Development in the UK Pharmaceutical Industry
3 January 1982
…the survey was carried out in 1980 there has been some relaxation of the regulations controlling the testing and marketing of new medicines. In particular, the delays to clinical trials…
Cystic Fibrosis
1 March 1986
…affected by the disease and their families. This paper looks at the nature and management of CF, the improvement in prognosis, the possibilities for prevention and social and economic considerations….
Four Case Studies to Explore the Added Value of Oxford AHSN
9 January 2016
…in 2013. In order to do this, OHE Consulting and RAND Europe conducted analyses of four case study projects: 1. Anxiety & Depression Clinical Network: A targeted 5% improvement in…